First data from Europe’s first and largest prospective observational study of metastatic castration-resistant prostate cancer (mCRPC) presented at the 2015 European Cancer Congress (ECC2015)
- EMEA Innovative Medicine
- First data from Europe’s first and largest prospective observational study of metastatic castration-resistant prostate cancer (mCRPC) presented at the 2015 European Cancer Congress (ECC2015)
First data from Europe’s first and largest prospective observational study of metastatic castration-resistant prostate cancer (mCRPC) presented at the 2015 European Cancer Congress (ECC2015)
- X (Twitter)
Copy link